Details for Patent: 6,716,867

✉ Email this page to a colleague

Summary for Patent: 6,716,867

Title:	Use of dexmedetomidine for ICU sedation
Abstract:	The present invention relates to a method of sedating a patient while in the intensive care unit comprising administering dexmedetomidine of a pharmaceutically acceptable salt thereof to the patient, wherein the patient remains arousable and orientated.
Inventor(s):	Aantaa; Riku (Turku, FI), Bachand; Romeo (Mundelain, IL), Heinonen; Esa (Turku, FI)
Assignee:	Orion Corporation (Espoo, FI)
Application Number:	09/647,364
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,716,867
Patent Claim Types: see list of patent claims	Use; Composition; Delivery;

Drugs Protected by US Patent 6,716,867

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,716,867

PCT Information
PCT Filed	March 31, 1999	PCT Application Number:	PCT/FI99/00266
PCT Publication Date:	October 07, 1999	PCT Publication Number:	WO99/49854

International Family Members for US Patent 6,716,867

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1069893	⤷ Sign Up	C01069893/01	Switzerland	⤷ Sign Up
Argentina	015744	⤷ Sign Up
Austria	347359	⤷ Sign Up
Australia	3149499	⤷ Sign Up
Australia	754484	⤷ Sign Up
Bulgaria	104797	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.